O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
301
Arvinas
ARVN
$583M
|
MB
Matthew Biegler
| $8 | $45 |
463%
upside
| Outperform |
12 Feb ‘25
7 months ago |
|
302
IBM
IBM
$241B
|
PS
Param Singh
| $259.11 | $320 |
24%
upside
| Outperform |
11 Feb ‘25
7 months ago |
|
303
Veeco
VECO
$1.49B
|
RS
Rick Schafer
| $24.81 | $35 |
41%
upside
| Outperform |
7 Feb ‘25
7 months ago |
|
304
Varex Imaging
VREX
$485M
|
SK
Suraj Kalia
| $11.59 | $23 |
98%
upside
| Outperform |
7 Feb ‘25
7 months ago |
|
305
Regal Rexnord
RRX
$9.45B
|
CG
Christopher Glynn
| $142.39 | $190 |
33%
upside
| Outperform |
7 Feb ‘25
7 months ago |
|
306
American Superconductor
AMSC
$2.25B
|
CR
Colin Rusch
| $49.85 | $39 |
22%
downside
| Outperform |
7 Feb ‘25
7 months ago |
|
307
Costco
COST
$431B
|
RP
Rupesh Parikh
| $979.25 | $1,130 |
15%
upside
| Outperform |
6 Feb ‘25
7 months ago |
|
308
CyberArk
CYBR
$23.6B
|
SE
Shaul Eyal
| $469.49 | $420 |
11%
downside
| Outperform |
5 Feb ‘25
7 months ago |
|
309
T-Mobile US
TMUS
$273B
|
TH
Timothy Horan
| $242.72 | $275 |
13%
upside
| Outperform |
31 Jan ‘25
7 months ago |
|
310
Roper Technologies
ROP
$55.9B
|
CG
Christopher Glynn
| $519.67 | $640 |
23%
upside
| Outperform |
31 Jan ‘25
7 months ago |
|
311
Dover
DOV
$24.4B
|
BB
Bryan Blair
| $174.68 | $225 |
29%
upside
| Outperform |
31 Jan ‘25
7 months ago |
|
312
Cigna
CI
$80.3B
|
MW
Michael Wiederhorn
| $302.01 | $375 |
24%
upside
| Outperform |
31 Jan ‘25
7 months ago |
|
313
Ovid Therapeutics
OVID
$88.2M
|
FB
Francois Brisebois
| $1.24 | $4 |
223%
upside
| Outperform |
29 Jan ‘25
7 months ago |
|
314
SGHC Ltd
SGHC
$6.65B
|
JK
Jed Kelly
| $13.15 | $11 |
16%
downside
| Outperform |
29 Jan ‘25
7 months ago |
|
315
Shoals Technologies Group
SHLS
$1.11B
|
CR
Colin Rusch
| $6.65 | $10 |
50%
upside
| Outperform |
28 Jan ‘25
7 months ago |
|
316
Twilio
TWLO
$16.4B
|
IK
Ittai Kidron
| $107 | $160 |
50%
upside
| Outperform |
24 Jan ‘25
7 months ago |
|
317
Teladoc Health
TDOC
$1.38B
|
MW
Michael Wiederhorn
| $7.80 | $12 |
54%
upside
| Outperform |
24 Jan ‘25
7 months ago |
|
318
Evolent Health
EVH
$1.16B
|
JJ
Jeff Jones
| $9.99 | $18 |
80%
upside
| Outperform |
24 Jan ‘25
7 months ago |
|
319
Addus HomeCare
ADUS
$2.11B
|
AW
Ari Wald
| $113.05 | $150 |
33%
upside
| Outperform |
24 Jan ‘25
7 months ago |
|
320
Toast
TOST
$23.9B
|
RK
Rayna Kumar
| $40.92 | $46 |
12%
upside
| Outperform |
24 Jan ‘25
7 months ago |
|
321
Exelixis
EXEL
$10.3B
|
JO
Jay Olson
| $38.28 | $33 |
14%
downside
| Perform |
24 Jan ‘25
7 months ago |
|
322
Life Time Group Holdings
LTH
$6.42B
|
BN
Brian Nagel
| $28.64 | $43 |
50%
upside
| Outperform |
23 Jan ‘25
7 months ago |
|
323
Tarsus Pharmaceuticals
TARS
$2.4B
|
FB
Francois Brisebois
| $56.49 | $72 |
27%
upside
| Outperform |
22 Jan ‘25
7 months ago |
|
324
Take-Two Interactive
TTWO
$45.7B
|
MY
Martin Yang
| $247.86 | $215 |
13%
downside
| Outperform |
21 Jan ‘25
7 months ago |
|
325
EnerSys
ENS
$3.92B
|
NK
Noah Kaye
| $103.77 | $115 |
11%
upside
| Outperform |
17 Jan ‘25
7 months ago |
|